Turkish Adaptation and Validation of the Burnt Hand Outcome Tool (BHOT)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNecmettin Erbakan University
About this trial
The goal of this observational study is to evaluate the validity and reliability of the Turkish adaptation of the Burnt Hand Outcome Tool (BHOT) in adults with a history of hand burns. The participant population will include adults aged 18 years and older who have experienced unilateral or bilateral hand burns and can read and understand Turkish.The main questions this study aims to answer are:
Does the Turkish version of the BHOT demonstrate high internal consistency, test-retest reliability, and construct validity? How strongly are BHOT scores associated with objective hand function measures such as grip strength and sensory evaluation? Participants will not be assigned to comparison groups, as this is a methodological validation study.
Participants will: Complete a sociodemographic information form. Complete the Turkish version of the BHOT and the QuickDASH questionnaire. Undergo objective assessments including hand grip strength using a dynamometer and sensory evaluation using Semmes-Weinstein monofilaments. Participate in repeated assessments at baseline, 1 month, 3 months and 6 months for reliability analyses.
Eligibility criteria
Qualifiers
Age 18 years or older
History of second-degree or higher burn injury in one or both hands
Ability to read and understand Turkish
Willingness to participate and provision of written informed consent
Disqualifiers
History of trauma, surgery, or rheumatologic disease affecting hand function prior to the burn injury
Age under 18 years
Cognitive impairment or psychiatric disorder preventing completion of the questionnaires
Refusal to participate or withdrawal from the study at any time
Trial design
Treatments tested in this trial
- Burnt Hand Outcome Tool (BHOT) - Turkish Version
Treatment groups
No treatment groups listed
Sponsors and collaborators
Necmettin Erbakan University
Lead sponsor
Konya City Hospital
Collaborator
Source ClinicalTrials.gov